2025 - 2029 | Standing Member, NIH, Biochemical and Cellular Oncogenesis (BCO) Study Section , NIH |
2024 | Selected among 2024 Accelerator for Cancer Therapeutics Cohort by TMC Innovation, TMC Innovation |
2021 - 2023 | Pilot Study Award, Rivkin Center for Ovarian Cancer |
2016 - 2017 | Pilot Study Award, Rivkin Center for Ovarian Cancer |
2014 - 2019 | BCM Oncology Scholars Training Program (T32), NIH/NCI |
2013 | Dan L. Duncan Cancer Center pilot project award, Baylor College of Medicine |
2012 | Breast SPORE Translational Research Award, Baylor College of Medicine |
2010 | Dan Duncan Professorship of Oncology, Baylor College of Medicine, Baylor College of Medicine |
2007 - 2014 | America’s Top Doctors (Hematology), Castle Connolly Medical Ltd. |
2007 - 2011 | America’s Top Doctors for Cancer, Castle Connolly Medical Ltd. |
2006 - 2011 | Leukemia & Lymphoma Society Scholar, University of Alabama at Birmingham |
2002 - 2005 | General Motors Cancer Research Scholar, University of Alabama at Birmingham |
2001 - 2004 | Breast SPORE Career Development Award, UAB, University of Alabama at Birmingham |
2001 - 2004 | Howard Hughes Medical Institute Junior Faculty Development Award, University of Alabama at Birmingham |
1998 - 2001 | Physician Scientist Award, Damon Runyon-Walter Winchell Foundation , Duke University |
1998 | American Society of Hematology Fellow Scholar Award |
1993 | the Martin and Carol Macht Research Prize, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine |
1979 - 1986 | Book Coupon Awards, National Taiwan University College of Medicine, National Taiwan University |